Health
New immunotherapy shows promise against rare childhood cancer – EurekAlert
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma,…
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results in children with neuroblastoma, a rare form of childhood cancer.
For this proof-of-principle study, researchers at the UCL Great Ormond Street Institute for Child Health (GOS ICH) and the UCL Cancer Institute modified the patient’s own T-cells (a type of immune cell), equipping them to recognise and kill neuroblastoma tumour cells.
Twelve children with relapsed…
-
Noosa News19 hours agoProtest calls for shark net removal
-
General18 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News21 hours agoNew playground equipment encourages children to learn through ‘risky play’
-
Business22 hours ago1 ASX dividend stock down 38% I’d buy right now